These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9820638)
1. Implications for the use of X-chromosome inactivation patterns and their relevance to the myeloproliferative disorders. Gilbert HL; Acharya J; Pearson TC Eur J Haematol; 1998 Oct; 61(4):282-3. PubMed ID: 9820638 [No Abstract] [Full Text] [Related]
2. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of clonal development in chronic myeloproliferative disorders. Ferraris AM; Mangerini R; Racchi O; Rapezzi D; Rolfo M; Casciaro S; Gaetani GF Am J Hematol; 1999 Feb; 60(2):158-60. PubMed ID: 9929111 [TBL] [Abstract][Full Text] [Related]
4. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Champion KM; Gilbert JG; Asimakopoulos FA; Hinshelwood S; Green AR Br J Haematol; 1997 Jun; 97(4):920-6. PubMed ID: 9217198 [TBL] [Abstract][Full Text] [Related]
5. Inactivated X chromosome fold in human leukemia and related clonal disorders. Avalos MR; Léonard C; Mielot F; Tchernia G Hum Genet; 1989 Jul; 82(4):386-8. PubMed ID: 2737671 [TBL] [Abstract][Full Text] [Related]
6. Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder. O'Reilly J; Crawford J; Uzaraga J; Cannell P Cancer Genet Cytogenet; 2005 Apr; 158(1):81-3. PubMed ID: 15771910 [TBL] [Abstract][Full Text] [Related]
7. Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis. Mitterbauer G; Winkler K; Gisslinger H; Geissler K; Lechner K; Mannhalter C Am J Clin Pathol; 1999 Jul; 112(1):93-100. PubMed ID: 10396290 [TBL] [Abstract][Full Text] [Related]
8. X chromosome inactivation patterns in normal females. Racchi O; Mangerini R; Rapezzi D; Rolfo M; Gaetani GF; Ferraris AM Blood Cells Mol Dis; 1998 Dec; 24(4):439-47. PubMed ID: 9880240 [TBL] [Abstract][Full Text] [Related]
9. Isodicentric X chromosome in myeloproliferative disorders. Temperani P; Zucchini P; Emilia G; Sacchi S; Selleri L; Torelli U Acta Haematol; 1989; 81(3):152-4. PubMed ID: 2496563 [TBL] [Abstract][Full Text] [Related]
10. JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Rumi E; Passamonti F; Pietra D; Della Porta MG; Arcaini L; Boggi S; Elena C; Boveri E; Pascutto C; Lazzarino M; Cazzola M Cancer; 2006 Nov; 107(9):2206-11. PubMed ID: 16998940 [TBL] [Abstract][Full Text] [Related]
11. Isodicentric (X)(q13): a new characteristic chromosomal anomaly in myeloproliferative syndrome? Petit P; Fryns JP; Masure R; Van Den Berghe H Cancer Genet Cytogenet; 1982 Dec; 7(4):339-41. PubMed ID: 7165869 [No Abstract] [Full Text] [Related]
12. [X chromosome inactivation pattern in elderly women over 70 years of age]. Iurov IIu; Willard L; Vorsanova SG; Demidova IA; Goĭko EA; Shal'nova SA; Shkol'nikova MA; Olfer'ev AM; Iurov IuB Tsitol Genet; 2004; 38(4):49-54. PubMed ID: 15715165 [TBL] [Abstract][Full Text] [Related]
13. Clonality in myeloproliferative disorders. Blanchard KL; Gilliland DG; Bunn HF Am J Med Sci; 1992 Aug; 304(2):125-30. PubMed ID: 1503111 [TBL] [Abstract][Full Text] [Related]
14. Age-related reactivation of an X-linked gene close to the inactivation centre in the mouse. Brown S; Rastan S Genet Res; 1988 Oct; 52(2):151-4. PubMed ID: 3209066 [No Abstract] [Full Text] [Related]
15. Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Acharya J; Westwood NB; Sawyer BM; Messinezy M; Burroughs AK; Mehta AB; Pearson TC Eur J Haematol; 1995 Nov; 55(5):315-21. PubMed ID: 7493678 [TBL] [Abstract][Full Text] [Related]
16. Skewed X-chromosome inactivation: cause or consequence? Brown CJ J Natl Cancer Inst; 1999 Feb; 91(4):304-5. PubMed ID: 10050859 [No Abstract] [Full Text] [Related]
17. [X chromosome inactivation--a biological phenomenon of clinical significance for women]. Orstavik KH Tidsskr Nor Laegeforen; 1999 Mar; 119(7):972-5. PubMed ID: 10210959 [TBL] [Abstract][Full Text] [Related]
18. A rapidly progressive chronic myeloproliferative disease with isolated trisomy 6. Wong KF Cancer Genet Cytogenet; 2004 Mar; 149(2):176-7. PubMed ID: 15036897 [No Abstract] [Full Text] [Related]
19. Aging and aneuploidy: evidence for the preferential involvement of the inactive X chromosome. Abruzzo MA; Mayer M; Jacobs PA Cytogenet Cell Genet; 1985; 39(4):275-8. PubMed ID: 4053692 [TBL] [Abstract][Full Text] [Related]
20. Myeloproliferative disorders: usefulness of X-linked probes in diagnosis. Taylor KM; Shetta M; Talpaz M; Kantarjian HM; Hardikar S; Chinault AC; McCredie KB; Spitzer G Leukemia; 1989 Jun; 3(6):419-22. PubMed ID: 2566725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]